The progressive long-term functional and biochemical downregulation of CFTR at the transcriptional and posttranslational level by chronic CS treatment, however, will require the implementation of additional or alternative therapeutic approaches to alleviate the compromised channel activity at the apical PM of airway epithelia. This evidence concerns the gene CFTR and Cowden syndrome 1.